Wearable Fitness Trackers

Direct randomized-trial evidence that wearable activity trackers increase physical activity is strong and consistent. A 2022 umbrella review of 39 systematic reviews and meta-analyses (163,992 participants; Lancet Digital Health) found trackers improved physical activity (SMD 0.3-0.6) — roughly +1,800 steps/day, +40 minutes/day of walking, and about 1 kg of weight loss — with benefits sustained over time. A 2025 meta-analysis of 23 RCTs in community-dwelling older adults (4,566 participants; JMIR) confirmed a significant increase in daily step count (SMD 0.58) and activity time (SMD 0.28), while finding no significant effect on body composition or physical-function tests. The link from higher step counts to hard health outcomes comes from prospective cohort data: a 2025 dose-response meta-analysis (Lancet Public Health; 57 studies from 35 cohorts, device-measured steps) found that, compared with 2,000 steps/day, 7,000 steps/day was associated with 47% lower all-cause mortality (HR 0.53), 47% lower cardiovascular mortality, 38% lower dementia risk, 37% lower cancer mortality, 28% fewer falls, 25% lower cardiovascular disease incidence, 22% fewer depressive symptoms, and 14% lower type 2 diabetes risk; the 6% reduction in cancer incidence was not statistically significant. Interpret cautiously: the outcome data are observational (association, not proof of causation), several outcomes rest on only two to four studies, and a tracker is a monitoring and behavior-change tool, not a treatment for any disease. Leading consumer devices include Oura, WHOOP, Apple Watch, and Garmin. Key references: Ding D, et al. Lancet Public Health 2025;10(8):e668-e681 (https://doi.org/10.1016/S2468-2667(25)00164-1); Ferguson T, et al. Lancet Digit Health 2022;4(8):e615-e626 (https://doi.org/10.1016/S2589-7500(22)00111-X); Li R, et al. J Med Internet Res 2025;27:e59507 (https://doi.org/10.2196/59507).

Evidence Scale